Search Results
10
Everything
DEADLINE ALERT for ELF, FLNC, EU, and TFII: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
March 28, 2025 12:22 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, March 28, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
DEADLINE ALERT for TBBK, ZYXI, PPTA, and UCTT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
March 28, 2025 12:11 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, March 28, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
DEADLINE ALERT for SWKS, MRVI, APP, and RC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
March 27, 2025 12:20 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, March 27, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
Nutrify Today C-Suite Sumflex to Unite Global Nutraceutical Leaders in Mumbai
March 27, 2025 10:10 ET
|
Nutrify Today
Nutrify Today C-Suite Sumflex 2025 will convene top executives, policymakers, investors, and medical leaders on May 8-9 in Mumbai.
Chemomab Reports Positive Results in Nebokitug Phase 2 PSC Open Label Extension Trial Showing Continued Broad and Substantial Improvements in Key Liver Biomarkers
March 27, 2025 08:30 ET
|
Chemomab Therapeutics
Reported positive 48-week nebokitug data from Phase 2 PSC trial. Reduced risk for disease progression and showed improvement in key markers of fibrosis.
BIO-key Trims 2024 Net Loss 49% to $4.3M, Reflecting Higher Gross Margin and Lower Operating Costs, Offsetting 11% Revenue Decrease Due to Business Transition; Hosts Investor Call Today at 10am ET
March 27, 2025 07:58 ET
|
BIO-key International, Inc.
BIO-key Trims 2024 Net Loss 49% to $4.3M, Reflecting Higher Gross Margin & Lower Operating Costs, Offsetting 11% Revenue Decrease From Business Transition.
DEADLINE ALERT for SMTC, QUBT, and RKLB: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
March 26, 2025 12:18 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, March 26, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
DEADLINE ALERT for ESTC, MRK, and FMC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
March 26, 2025 12:13 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, March 26, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
DEADLINE ALERT for ALAR, VG, STZ, and TTD: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
March 25, 2025 12:15 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, March 25, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
DEADLINE ALERT for IAS, MODV, and TIXT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
March 25, 2025 12:10 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, March 25, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...